These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

75 related items for PubMed ID: 589946

  • 1. [Use of calcitonin in the treatment of bone metastases of prostatic carcinoma].
    Di Silverio F, Giacobini S, Liberti M, Fragomeri R, Petrone U.
    Clin Ter; 1977 Oct 15; 83(1):3-15. PubMed ID: 589946
    [No Abstract] [Full Text] [Related]

  • 2. [Successful relief of severe pain from bone metastases of carcinoma of the prostate by the treatment with P32].
    Nakaarai K, Tokizane M, Okuda N, Ito S.
    Hinyokika Kiyo; 1966 Dec 15; 12(12):1429-34. PubMed ID: 4167082
    [No Abstract] [Full Text] [Related]

  • 3. Fluoride therapy in prostatic carcinoma metastatic to bone. Preliminary report.
    Scott WP.
    N C Med J; 1968 Apr 15; 29(4):164-5. PubMed ID: 5240672
    [No Abstract] [Full Text] [Related]

  • 4. [Treatment of pain in bone metastases of prostatic carcinoma through unilateral left adrenalectomy].
    Archimbaud JP, des Roseaux M, Picq P.
    J Urol Nephrol (Paris); 1973 Dec 15; 79(12 Pt 2):415-9. PubMed ID: 4140920
    [No Abstract] [Full Text] [Related]

  • 5. [Combination of P32 and testosterone in the treatment of pain due to osseous metastasis of prostate neoplasms].
    García de la Peña E, Sánchez Martín JA, Linazasoro JM, Cifuentes Delatte L.
    Rev Clin Esp; 1974 Sep 30; 134(6):527-34. PubMed ID: 4141512
    [No Abstract] [Full Text] [Related]

  • 6. [Therapeutic indications for calcitonin. Experimental examination in some pathologic conditions].
    Perraro F, Piccini F, Donati E.
    Folia Endocrinol; 1972 Oct 30; 25(5):411-23. PubMed ID: 4679243
    [No Abstract] [Full Text] [Related]

  • 7. Management of malignant disease metastatic to bone by hormonal alterations.
    Mellette SJ.
    Clin Orthop Relat Res; 1970 Oct 30; 73():73-88. PubMed ID: 5479779
    [No Abstract] [Full Text] [Related]

  • 8. [Results of calcitonin therapy of the painful symptoms caused by osteolytic metastases of prostatic carcinoma].
    Fabris P, Strada G, Tonazzi G, Rossi A, Franchini V, Scardino E.
    Chir Ital; 1980 Dec 30; 32(6):1740-4. PubMed ID: 6166404
    [Abstract] [Full Text] [Related]

  • 9. [Scintigraphic presentation of bone metastases in prostatic carcinoma].
    Dienstl VE, Hinteregger H, Bergmann M, Herbinger W.
    Wien Med Wochenschr; 1975 Jun 20; 125(25-27):388-91. PubMed ID: 1220285
    [No Abstract] [Full Text] [Related]

  • 10. [Endocrine-surgical treatment of skeletal metastases].
    Dagradi A, Petronio R.
    Clin Ortop; 1972 Jun 20; 23(1):1-25. PubMed ID: 5084890
    [No Abstract] [Full Text] [Related]

  • 11. Cancer of the prostate. Treating metastasis with estramustine phosphate.
    Hoeft RT, Jones AG.
    Am J Nurs; 1982 May 20; 82(5):829-30. PubMed ID: 6918193
    [No Abstract] [Full Text] [Related]

  • 12. [Prostatic neoplasm with skeletal metastases. Exceptional survival and disappearance of the metastases after hormone therapy].
    Filippini U.
    Minerva Urol; 1969 May 20; 21(6):232-4. PubMed ID: 5403841
    [No Abstract] [Full Text] [Related]

  • 13. [Trepanobiopsy of the iliac bone in the diagnosis of bone metastasis of prostate carcinoma and in control of the efficacy of estrogen therapy].
    Mazin VV, Komarova LI, Mazina NM.
    Urol Nefrol (Mosk); 1977 May 20; (3):41-2. PubMed ID: 878087
    [No Abstract] [Full Text] [Related]

  • 14. Phosphorus 32 for intractable pain in carcinoma of the prostate.
    Johnson DE, Haynie TP.
    Tex Med; 1971 Mar 20; 67(3):57-9. PubMed ID: 4103609
    [No Abstract] [Full Text] [Related]

  • 15. Two unusual cases of metastasis of prostatic cancer: metastases to the spermatic cord and the epididymis.
    Wilenius R, Seppänen J.
    Ann Chir Gynaecol Fenn; 1969 Mar 20; 58(2):172-5. PubMed ID: 5370000
    [No Abstract] [Full Text] [Related]

  • 16. Understanding bone metastases: the key to the effective treatment of prostate cancer.
    Fidler IJ.
    Clin Adv Hematol Oncol; 2003 May 20; 1(5):278-9. PubMed ID: 16224421
    [No Abstract] [Full Text] [Related]

  • 17. [Proceedings: Value of cyproterone in the treatment of prostatic cancers with metastases].
    Bracci U.
    J Urol Nephrol (Paris); 1973 Dec 20; 79(12 Pt 2):405-6. PubMed ID: 4804409
    [No Abstract] [Full Text] [Related]

  • 18. [Metastases of prostatic cancer].
    Samsonov VA.
    Arkh Patol; 1985 Dec 20; 47(8):58-61. PubMed ID: 4074149
    [Abstract] [Full Text] [Related]

  • 19. [Experience with paraoxypropiophenone (Frenantol) in the treatment of dysplasias and metastasized carcinoma of the breast].
    Grapulin G.
    Chir Ital; 1967 Jun 20; 19(3):306-12. PubMed ID: 5188348
    [No Abstract] [Full Text] [Related]

  • 20. [Treatment of bone metastases by calcitonin].
    Campailla E.
    Nouv Presse Med; 1977 Oct 08; 6(33):2994. PubMed ID: 339198
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.